HOME >> BIOLOGY >> NEWS
Paradox in the lungs resolved

Researchers at National Jewish Medical and Research Center have discovered that a single class of molecules serves as the immune system's gatekeeper in the lungs, damping the immune response in some situations and promoting it in others.

The findings, published in the October 3 issue of the journal Cell, resolve an apparent paradox that prevented researchers from understanding how these versatile surveillance proteins function.

"The lung collectins can effectively discriminate between conditions in the lung that warrant an immune response and those that do not," said Peter Henson, Ph.D., Professor of Pediatrics at National Jewish Medical and Research Center. "They do this with a clever mechanism, inhibiting the immune response with one end of their structure and promoting it with the other."

The immune system must ride a fine line in its protection of the lung, whose surface area covers an area about the size of a tennis court. It must quickly sound the alarm when it detects a potentially harmful organism or molecule. But it must also tolerate a certain amount of irritation without calling out the inflammatory, disease-fighting tools, that can cause damage themselves.

The two lung collectins, surfactant proteins A and D (SP-A and SP-D), are widely recognized as members of the innate immune system, sentinels capable of initiating an inflammatory response to overcome infections and promote tissue repair.

However, recent experiments with mice contradicted this widely held view and raised serious questions about the role of the lung collectins. Mice engineered to lack the lung collectins actually demonstrate an enhanced inflammatory response, while mice overexpressing the lung collectins exhibited a reduced inflammatory response.

In their paper, Dr. Henson and his colleagues resolved this paradox with experiments showing that the lung collectins actually play two roles in the lungs, damping the immune response in some situ
'"/>

Contact: William Allstetter
allstetterw@njc.org
303-398-1002
National Jewish Medical and Research Center
2-Oct-2003


Page: 1 2

Related biology news :

1. Paradox of groundwater age has implications for hydrology
2. Paradoxical Gene Suppresses Tumors Yet Makes Them Grow
3. Infants sighs may reset breathing regulation mechanism as well as help lungs develop
4. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
5. Drinking wine, particularly white wine, may help keep lungs healthy, UB study finds
6. Mice could provide the key to growing human lungs for transplant
7. Lizards and salamanders may use lungs to hear, study says
8. Cystic fibrosis patients show too little salt in lungs, will need long-lasting treatments
9. Researchers discover gene responsible for cilia, lungs natural cleaning system
10. UI researchers develop test indicating cystic fibrosis lungs are infected with bacterial biofilms
11. Marathon runners, swimmers, and cross-country skiers beware: intensive exercise is bad for your lungs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Paradox the lungs resolved

(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
(Date:11/21/2014)... -- According to a new market research ... Access Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), ... Geography - Global Forecasts to 2020", published by MarketsandMarkets, ... around $25 Billion in 2014 and is expected to ... of 8.69%. Browse 116 market data Tables ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
(Date:12/19/2014)... -- Decision Resources Group finds that the Asia ... through 2023 as the aging population, increasing adoption of ... all spur procedure volumes. Growth will be particularly rapid ... and India , where rising ... a larger proportion of the population. Other ...
(Date:12/17/2014)... NY (PRWEB) December 16, 2014 The ... changes since 2013, which is why IBISWorld updated its ... industry continues to benefit from an intensified focus on ... proposal for new emission standards for power plants and ... operators. According to IBISWorld Industry Analyst Sarah Kahn, “a ...
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
Breaking Biology Technology:Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
Cached News: